KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $19.3 million.

  • Chemed's Tax Provisions fell 2354.57% to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.6 million, marking a year-over-year decrease of 166.52%. This contributed to the annual value of $97.5 million for FY2024, which is 2518.43% up from last year.
  • According to the latest figures from Q3 2025, Chemed's Tax Provisions is $19.3 million, which was down 2354.57% from $18.6 million recorded in Q2 2025.
  • Over the past 5 years, Chemed's Tax Provisions peaked at $29.8 million during Q4 2024, and registered a low of $17.0 million during Q2 2023.
  • In the last 5 years, Chemed's Tax Provisions had a median value of $19.6 million in 2022 and averaged $21.0 million.
  • Over the last 5 years, Chemed's Tax Provisions had its largest YoY gain of 6868.61% in 2021, and its largest YoY loss of 3299.26% in 2021.
  • Chemed's Tax Provisions (Quarter) stood at $21.5 million in 2021, then decreased by 5.71% to $20.3 million in 2022, then rose by 25.97% to $25.5 million in 2023, then grew by 16.7% to $29.8 million in 2024, then tumbled by 35.22% to $19.3 million in 2025.
  • Its Tax Provisions stands at $19.3 million for Q3 2025, versus $18.6 million for Q2 2025 and $23.9 million for Q1 2025.